1-3 of 3
Xiaolin Wang
Close
Sort by
Journal Articles

Pharmacokinetics, Efficacy and Safety Evaluation of FRSW107 in Previously Treated Hemophilia a Patients: A Multicentre, Open-Label, Non-Randomized Phase III Study

Feng Xue, Hu Zhou, Yun Chen, Jing Sun, Xiaojing Zeng, Chenghao Jin, Pingchong Lei, Zhenyu Li, Yaming Xi, Lirong Sun, Zhongguang Cui, Xielan Zhao, Linhua Yang, Bangshuo Zhang, Aizong Shen, Runhui Wu, Xiaolin Wang, Ling Liu, Yuhua Wang, Lizhi Sun, Yan Xia, Weichuan Mo, Dong Yuan, Jiwei Lou, Taiping Gan, Chengli Hu, Chen Ling, Hongsheng Su, Yali Wang, Baolin Tang, Renchi Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 8468–8469.
https://doi.org/10.1182/blood-2022-158760
Published: 2022
Journal Articles

Exposure-Response of the Bruton Tyrosine Kinase Inhibitor, Acalabrutinib, in the Treatment of Hematologic Malignancies

Feng Jin, PhD, Ming Yin, PhD, Vinay Mandava, Helena Edlund, PhD, Marilee Andrew, PhD, Priti Patel, MD, Eric Masson, PharmD, Nidal Al-Huniti, PhD, Xiaolin Wang, ScD, J. Greg Slatter, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1268.
https://doi.org/10.1182/blood.V130.Suppl_1.1268.1268
Published: 2017
Journal Articles

Telomerase Inhibitor Imetelstat Therapy in Refractory Anemia with Ring Sideroblasts with or without Thrombocytosis

Ayalew Tefferi, MD, Aref Al-Kali, MD, Kebede H. Begna, MD, Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Xiaolin Wang, ScD, Ying Wan, PhD, Curtis A. Hanson, MD
Journal: Blood
Blood (2015) 126 (23): 55.
https://doi.org/10.1182/blood.V126.23.55.55
Published: 2015